Max Healthcare Institute has completed the acquisition 100% equity stake of Jaypee Healthcare (JHL) on 11 November 2024, upon acquisition of remaining 15,53,90,769 equity shares constituting to 36.35% equity stake for an aggregate consideration of Rs 227 crore. Consequently, JHL has become a wholly-owned subsidiary of the Company.Powered by Capital Market - Live News

Net profit of Max Healthcare Institute rose 1.85% to Rs 281.81 crore in the quarter ended September 2024 as against Rs 276.68 crore during the previous quarter ended September 2023. Sales rose 25.26% to Rs 1707.46 crore in the quarter ended September 2024 as against Rs 1363.16 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1707.461363.16 25 OPM %26.3928.42 - PBDT457.84424.30 8 PBT373.69366.42 2 NP281.81276.68 2 Powered by Capital Market - Live News

Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live News

Max Healthcare Institute announced that Kummamuri Narasimha Murthy (DIN: 00023046) completed his second consecutive term as an Independent Director of the Company on 25 September 2024 and consequently ceased to be a Director of the Company with effect fromend of the day on 25 September 2024.Powered by Capital Market - Live News

Max Healthcare Institute has allotted 2,06,091 equity shares under ESOS on 13 September 2024. With this allotment, the paid up equity share capital has increased to 97,21,32,053 equity shares of Rs 10 each. Powered by Capital Market - Live News